Literature DB >> 19081780

POTENTIAL NON-GROWTH USES OF rhIGF-I.

Roy J Kim1, Adda Grimberg.   

Abstract

Year:  2007        PMID： 19081780      PMCID： PMC2600514     

Source DB:  PubMed          Journal:  Growth Genet Horm        ISSN： 0898-6630


× No keyword cloud information.
  80 in total

Review 1.  Severe systemic complications of acromegaly.

Authors:  A Colao; R Pivonello; P Marzullo; R S Auriemma; M C De Martino; D Ferone; G Lombardi
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

Review 2.  Role of insulin-like growth factors in neuronal plasticity and neuroprotection.

Authors:  Ignacio Torres Aleman
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

3.  Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group.

Authors:  T Quattrin; K Thrailkill; L Baker; J Kuntze; P Compton; P Martha
Journal:  J Pediatr Endocrinol Metab       Date:  2001-03       Impact factor: 1.634

4.  Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.

Authors:  Shi-Yan Li; Cindy X Fang; Nicholas S Aberle; Bonnie H Ren; Asli F Ceylan-Isik; Jun Ren
Journal:  J Endocrinol       Date:  2005-09       Impact factor: 4.286

5.  Increased overnight growth hormone concentrations in diabetic compared with normal adolescents.

Authors:  J A Edge; D B Dunger; D R Matthews; J P Gilbert; C P Smith
Journal:  J Clin Endocrinol Metab       Date:  1990-11       Impact factor: 5.958

Review 6.  Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies.

Authors:  Sylvie Marleau; Mukandila Mulumba; Daniel Lamontagne; Huy Ong
Journal:  Cardiovasc Res       Date:  2005-10-10       Impact factor: 10.787

7.  Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure.

Authors:  H Ding; J D Kopple; A Cohen; R Hirschberg
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Direct effect of human growth hormone to inhibit glucose uptake in cultured human fibroblasts.

Authors:  S Takeda; J M Podskalny; P Gorden
Journal:  Metabolism       Date:  1984-07       Impact factor: 8.694

9.  Sensorineural hearing loss in insulin-like growth factor I-null mice: a new model of human deafness.

Authors:  R Cediel; R Riquelme; J Contreras; A Díaz; I Varela-Nieto
Journal:  Eur J Neurosci       Date:  2006-01       Impact factor: 3.386

10.  Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.

Authors:  Jean-Marc Schwarz; Kathleen Mulligan; Jeongae Lee; Joan C Lo; Michael Wen; Mustafa A Noor; Carl Grunfeld; Morris Schambelan
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958
View more
  2 in total

1.  Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.

Authors:  Madhu N Rao; Kathleen Mulligan; Viva Tai; Michael J Wen; Artem Dyachenko; Melissa Weinberg; Xiaojuan Li; Thomas Lang; Carl Grunfeld; Jean-Marc Schwarz; Morris Schambelan
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

Review 2.  Therapeutic Targeting of the IGF Axis.

Authors:  Eliot Osher; Valentine M Macaulay
Journal:  Cells       Date:  2019-08-14       Impact factor: 6.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.